Skip to main content
  • 419 Accesses

Synonyms

Angiotensin-converting enzyme inhibitors

Definition

Angiotensin converting enzyme (ACE) plays a central role in cardiovascular hemostasis. Its major function is the generation of angiotensin (ANG) II from ANG I and the degradation of bradykinin. Both peptides have profound impact on the cardiovascular system and beyond. ACE inhibitors are used to decrease blood pressure in hypertensive patients, to improve cardiac function, and to reduce work load of the heart in patients with cardiac failure.

Mechanism of Action

ACE inhibitors inhibit the enzymatic activity of angiotensin converting enzyme (ACE). This enzyme cleaves a variety of pairs of amino acids from the carboxy-terminal part of several peptide substrates. The conversion of ANG I to ANG II and the degradation of bradykinin to inactive fragments are considered the most important functions of ACE [13]. ACE inhibitors are nonpeptide analogues of ANG I. They bind tightly to the active sites of ACE, where they complex with a...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 849.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bader M, Paul M, Fernandesz-Alfonso M et al (1994) Molecular biology and biochemistry of the renin-angiotensin system, Chap. 11. In: Swales JD (ed) Textbook of hypertension. Blackwell Scientific Publications, Oxford, London, Edinburgh, pp 214–232

    Google Scholar 

  2. Bader M, Peters J, Baltatu O et al (2001)Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79:76–102

    Article  PubMed  CAS  Google Scholar 

  3. Gohlke P, Unger T (1994) Angiotensin converting enzyme inhibitors, Chap. 65. In: Swales JD (ed) Textbook of hypertension. Blackwell Scientific Publications, Oxford, London, Edinburgh, pp 1115–1127

    Google Scholar 

  4. Linz W, Martorana PA, Schölkens B (1990) Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Parmacol 15:S99–S109

    CAS  Google Scholar 

  5. Brogden RN, Todd PA, Sorkin EM (1988) Drugs 36:540–600

    Article  PubMed  CAS  Google Scholar 

  6. Wong J, Patel RA, Kowey PR (2004) The clinical use of angiotensin-converting enzyme inhibitors. Prog. Cardiovasc. Dis. 47, 116-130

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg New York

About this entry

Cite this entry

Peters, J. (2008). ACE Inhibitors. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-38918-7_1

Download citation

Publish with us

Policies and ethics